J. Goldman & Co’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Sell
175,400
-29,600
-14% -$226K 0.04% 381
2025
Q4
$1.99M Buy
205,000
+137,400
+203% +$1.17M 0.05% 316
2025
Q3
$283K Hold
67,600
0.01% 407
2025
Q2
$628K Buy
+67,600
New +$590K 0.02% 368
2024
Q4
Sell
-12,100
Closed -$133K 593
2024
Q3
$133K Buy
+12,100
New +$123K ﹤0.01% 424
2023
Q4
Sell
-54,000
Closed -$924K 452
2023
Q3
$924K Sell
54,000
-37,900
-41% -$744K 0.03% 240
2023
Q2
$2.13M Buy
+91,900
New +$1.8M 0.08% 203

Other funds holding REPL

J. Goldman & Co's REPL Position: Q1 2026 in Review

J. Goldman & Co sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 15,595 shares — an estimated $119K sold.

J. Goldman & Co first reported a position in REPL in Q4 2022 and held it in 8 quarters. The position peaked at $2.35M in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • J. Goldman & Co reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • J. Goldman & Co sold 15,595 Replimune Group shares in Q1 2026, an estimated $119K.
  • J. Goldman & Co first reported a position in Replimune Group in Q4 2022 and held it in 8 quarters.
  • J. Goldman & Co's Replimune Group position peaked at $2.35M in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.